Sunshine Biopharma Inc Ordinary Shares SBFM 深 滬
等待開盤 10-09 09:30:00 美东时间
1.68
+0.005
+0.30%
華盛通- 最 高1.70
- 今 開1.66
- 成交量 8.43万股
- 最 低 1.6201
- 昨 收 1.675
- 總市值 765.39万
- 52周最高 3.90
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.1693
- 委 比 86.63%
- 總股本 455.59万
- 歷史最高 19740.00
- 量 比 0.91
- 振 幅 4.77%
- 歷史最低 1.1693
- 每 手 1
- 風險率 0.65%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 最高186美元！戴尔科技或多家机构上调目标价； 高盛上调超微公司目标价至210美元
今日重点评级关注：富国银行：维持Kyverna Therapeutics"超配"评级，目标价从24美元升至27美元；Chardan Capital：维持Oculis Holding"买入"评级，目标价从33美元升至51美元
今天 10:51
Aegis Capital Reiterates Buy on Sunshine Biopharma, Maintains $7 Price Target
Aegis Capital analyst David Bouchey reiterates Sunshine Biopharma (NASDAQ:SBFM) with a Buy and maintains $7 price target.
今天 00:46
Sunshine Biopharma Filed U.S. Patent Application #20250276036 For "COMPOSITION FOR THE INHIBITION OF NRF2 AND USES THEREOF IN CANCER THERAPY"
https://ppubs.uspto.gov/api/pdf/downloadPdf/20250276036?requestToken=eyJzdWIiOiIyZDUxZWIxMy0xNzcwLTRmZDItYWZhYi1hZDZhM2MxMzVjOTQiLCJ2ZXIiOiIzYWZmYTM0My00ODdkLTQ4YTMtOWNmNy05NWFhM2IwOTYzZGMiLCJleHAiOjB9
09-05 04:00
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) stock rose 24.9% to $3.11 duri...
07-02 20:06
Sunshine Biopharma Announces That Its Wholly Owned Canadian Subsidiary, Nora Pharma, Has Launched Niopeg, The Company's First Biosimilar Drug
Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its
07-02 20:06
Sunshine Biopharma's Canadian Subsidiary, Nora Pharma, Launches Gabapentin, A New Generic Prescription Drug In The Therapeutic Class Of Anticonvulsants
Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its
06-11 20:56
Sunshine Biopharma reports Q1 results
Sunshine Biopharma press release (NASDAQ:SBFM): Q1 Revenue of $8.9M (+18.0% Y/Y). More on Sunshine Biopharma Seeking Alpha’s Quant Rating on Sunshine Biopharma Historical earnings data for Sunshine Bi...
05-16 16:05
Sunshine Biopharma Announces $2.46M Registered Direct Offering At $2.07 A Share
FORT LAUDERDALE, FL / ACCESS Newswire / April 2, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas
04-03 01:24
Sunshine Biopharma acquires marketing rights for two new antibiotics in Canada
Sunshine Biopharma (NASDAQ:SBFM) Monday said that it has signed a strategic agreement granting it the rights to market two new generic antibiotics in Canada. The company anticipates launching these ne...
03-24 20:19
Sunshine Biopharma Appoints New Chief Commercial Officer
The latest announcement is out from Sunshine Biopharma ( ($SBFM) ). Sunshine Bi...
01-16 08:09
